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Vascular endothelial growth factor (VEGF) is well known as the growth factor with
wide-ranging functions even in the central nervous system (CNS). Presently, most
attention is given to the investigation of its role in neuronal protection, growth and
maturation processes, whereby most effects are mediated through VEGF receptor
2 (VEGFR-2). The purpose of our current study is to provide new insights into the
impact of VEGF on immature and mature Purkinje cells (PCs) in accordance with
maturity and related receptor expression. Therefore, to expand our knowledge of VEGF
effects in PCs development and associated VEGFR-2 expression, we used cultivated
organotypic cerebellar slice cultures in immunohistochemical or microinjection studies,
followed by confocal laser scanning microscopy (CLSM) and morphometric analysis.
Additionally, we incorporated in our study the method of laser microdissection, followed
by quantitative polymerase chain reaction (qPCR). For the first time we could show
the age-dependent VEGF sensitivity of PCs with the largest promoting effects being
on dendritic length and cell soma size in neonatal and juvenile stages. Once mature,
PCs were no longer susceptible to VEGF stimulation. Analysis of VEGFR-2 expression
revealed its presence in PCs throughout development, which underlined its mediating
functions in neuronal cells.
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INTRODUCTION
Senger et al. (1983) first described the vascular endothelial growth factor (VEGF) as a tumor-
secreted vascular permeability protein. VEGF-A, in the following referred to as VEGF, is the
founding member of a homodimeric disulfide bound glycoprotein family, completed by VEGF-B,
-C, -D, -E, -F and the placenta growth factor (PIGF; Neufeld et al., 1999; Ferrara et al., 2003).
At least nine different isoforms of VEGF are known (VEGF121, 145, 148, 162, 165, 165b, 183, 189, 206),
generated through alternative mRNA splicing of the VEGF gene (Robinson and Stringer, 2001;
Takahashi and Shibuya, 2005; Beazley-Long et al., 2013), whereby VEGF-A165 is the most abundant
and biologically active form in mammalian species (Ferrara et al., 2003).
VEGF molecules are able to bind to different receptors such as VEGFR-1, -2 (KDR,) and
-3 (FLT-1, FLK-1, FLT-4), which belong to the family of receptor tyrosin kinases (Neufeld
et al., 1999). These transmembrane proteins contain a tyrosin kinase sequence in their
intracellular part, which is interrupted by a kinase insert domain, a transmembrane region and
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an extracellular part with seven immunoglobulin-like domains
(Ferrara et al., 2003). VEGFR-3 binds VEGF-C and VEGF-D,
and is mainly expressed in lymphatic endothelium where
it is responsible for inducing lymphangiogenesis (Veikkola
et al., 2001). Furthermore, VEGFR-3 regulates developmental
processes and adult neuronal function in the cerebellum (Hou
et al., 2011). The function of VEGFR-1 is still under debate, as it
binds VEGF-A, but also PIGF and VEGF-B. VEGFR-1 is likely
to function as a decoy-receptor to transmit mitogenic signals
(Ferrara et al., 2003), and is important in pathological conditions
such as inflammation and cancer (Takahashi and Shibuya, 2005).
VEGF-A165 and its corresponding VEGFR-2 mediate endothelial
survival and growth, but are also strongly expressed in the
nervous system (Takahashi and Shibuya, 2005; Zachary, 2005).
The small molecule axitinib is a tyrosine kinase inhibitor, which
is able to perturb VEGF pathways by specifically blocking the
tyrosine residue 1214 (tyr 1214) phosphorylation of the VEGF-
receptors. As a consequence, axitinib inhibits signal transduction
mediated through the VEGFR-2 as well as VEGFR-1 and -3
(Kelly and Rixe, 2009).
As an angiogenic, endothelial, cell mitogen and survival
factor, VEGF is best known for its role in angiogenesis and
vasculogenesis (Ferrara et al., 2003; Shibuya, 2008). VEGF
is subsequently expressed under conditions such as hypoxia,
ischemia and injury (Shweiki et al., 1992; Banai et al.,
1994). It promotes vascular development, permeability and
endothelial outspreading (Senger et al., 1983; Roberts and Palade,
1995).
Currently, there is a high interest in the impact of VEGF on
the nervous system. Other than its important role in neuronal
proliferation and migration (Zhu et al., 2003; Ruiz de Almodovar
et al., 2010), VEGF promotes neuron survival, regeneration,
neurite outgrowth, growth cone guidance, axonal and neuronal
growth and maturation (Sondell et al., 1999; Khaibullina et al.,
2004; Ruiz de Almodovar et al., 2009; Foehring et al., 2012;
Olbrich et al., 2013). Besides the neurogenic, neuroprotective and
additional neurotrophic impact on the nervous system (Sondell
et al., 1999; Rosenstein et al., 2003; Zachary, 2005; Beazley-Long
et al., 2013), an increasing number of studies are focusing on
VEGF as a stimulator of neurogenesis during development and
adulthood (Jin et al., 2002; Fabel et al., 2003; Schänzer et al.,
2004).
Moreover, a recent study detected a positive effect of VEGF on
the dendritogenesis of interneurons in the olfactory bulb (Licht
et al., 2010). Cvetanovic et al. (2011) investigated the impact
of VEGF inhibitors on the survival and dendritic outgrowth
of neonatal Purkinje cells (PCs) using primary cultures of
postnatal day 1 (p1) spinocerebellar ataxia 1 (SCA1) mice
cerebella. These experiments pointed out that low levels of
VEGF negatively influenced dendritogenesis and survival of
PCs. However, heretofore, few studies were published suggesting
that VEGF has a particular role in neuronal plasticity, neurite
maturation and dendrite formation.
To gain a deeper insight into the role of VEGF for
the development of cerebellar tissue, especially on PC
dendritogenesis and spinogenesis, our study was performed
with organotypic cerebellar slice cultures. During PC growth,
the morphology of these principle cerebellar neurons
changes dramatically, which starts during embryonic
development and proceeds into the juvenile stage. At
birth PCs are unpolarized neurons, with small soma and
multipolar perisomatic dendrites (McKay and Turner,
2005). Subsequently, polarized neurons with one or two
main branches are established, which become more and
more ramified during maturation. Matured PCs display a
huge, unipolar, highly branched dendritic arbor covered with
numerous dendritic spines. After 30 days of development
qualitative but almost no quantitative changes of dendritic arbor
morphology are detectable (Altman, 1972; Berry and Bradley,
1976).
It is most likely that VEGF is indeed involved in the
physiological maturation process of PCs. For clinical reasons
the possible impact of VEGF on adult PC has become a
point of focus. It is of significant therapeutic interest whether
VEGF is able to induce growth and maturation in PCs during
certain developmental stages. Thus, one aim of the current
study was to investigate, whether dendritogenesis, somatogenesis
and spinogenesis in neonatal, juvenile and mature PCs can
be stimulated by VEGF. Besides this we investigated the
differential expression of VEGFR-2 in neonatal, juvenile and
adult PCs by employing methods of immunohistochemistry,
in situ hybridization and laser microdissection, followed by
quantitative polymerase chain reaction (qPCR). Finally, the
effects of VEGF on PCs were examined to find out whether
they are inducible through molecular mechanisms of the
VEGFR-2 signaling pathway by blocking studies combined with
morphometric analyses.
MATERIALS AND METHODS
Cell Cultures
Primary cerebellar slice cultures (stages p6–p30) were prepared
as described previously (Meller et al., 2005; Wessel et al., 2014).
All procedures were conducted under established standards
of the German federal state of Northrhine Westphalia, in
accordance with the European Communities Council Directive
2010/63/EU on the protection of animals used for scientific
purposes.
The studies have been performed under the terms of the
German animal protection law. Wistar rat pups at postnatal
day 1 and day 9 (p1, p9) were used to obtain primary
cerebellar slice cultures according to the roller tube technique
(Wessel et al., 2014). Rat pups were decapitated, followed
by dissection of the brain. Cerebella were isolated from the
forebrain and brainstem, and the pia mater and superficial
blood vessels were removed under a binocular microscope. Using
the McIlwain tissue chopper, cerebella were cut with a razor
blade into parasagittal slices with a thickness of 275 µm. After
chopping, these slices were separated carefully and attached
to collagen-coated (C7661; Sigma-Aldrich) glass cover slips
(32 mm; Kindler, Freiburg, Germany) with 10 µl plasma (P3266;
Sigma-Aldrich) and 10µl thrombin (605157; Calbiochem). After
coagulation, each cover slip was placed into a roller tube with
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an additional 1.3 ml nutrient medium. The medium contained
25% heat-inactivated fetal horse serum (S9135; Biochrom), 15%
Hanks-Medium (H1641; Sigma-Aldrich), 6.5 mg/ml glucose,
basal medium eagle (BME, B1522; Sigma-Aldrich), 0.01g/ml
penicillin (P3032; Sigma-Aldrich), 0.01g/ml L-glutamine (G7513;
Sigma-Aldrich), and 25 ng/ml nerve growth factor (NGF-
7S, N0513; Sigma-Aldrich). Finally, these slice cultures were
placed in a roller-drum incubator at a temperature of 37◦C,
which rotated slowly at the speed of four rounds per
minute.
After 6 days in vitro (div) a mitosis inhibitor mixture
(0.33 mM Uridine, 0.33 mM Cytosine-ß-D-arabinofuranoside
hydrochloride, 0.33 mM 1-(2-Desoxy-ß-D-ribofuranosyl)-5-
fluoruracil; U3003, C6645; Sigma-Aldrich; Serva 21555) was
added to the slice cultures for 24 h to inhibit fibroblast
proliferation, whereas after the 7th div nutrient medium
was used, with a reduced heat-inactivated fetal horse serum
concentration (15%). During the incubation period of up to
21 div, the nutrient medium was replaced twice per week.
Experimental Groups
Experiments were performed with three different cerebellar slice
culture groups to examine the impact of VEGF on neonatal
(group 1: p1 + 5 div), juvenile (group 2: p1 + 16 div) and mature
PCs (group 3: p9 + 21 div). After these specific incubation times,
the method of microinjection or immunohistochemistry were
performed.
To be able to use the microinjection technique, slice cultures
have to flatten for a minimal amount of 2 weeks in vitro. To
investigate developing PCs we chose the stage p1 plus 16 div PCs
as the juvenile experimental group. For the analysis of mature
PCs we had to use p9 rats since it is known to achieve best
possible results in regard to cell survival (Krah andMeller, 1999).
To analyze the effects on dendritic maturation in these cultures
an additional period of 21 div is meaningful, in which the PCs are
able to develop their dendritic shape.
In Vitro Treatment of PCs
The impact of VEGF (V4512, Sigma Aldrich) on the morphology
of PC dendrites was investigated in cerebellar slice cultures of
p1 rats. In comparison to controls, slice cultures were incubated
with VEGF (c = 0.1 µg/ml) nutrient medium as described
previously (Jin et al., 2006), with a mixture of VEGF (c = 0.1
µg/ml) and axitinb (c = 0.01 mg/ml), or solely with axitinib
(c = 0.01 mg/ml) for 48 h. Afterwards they were fixed with 4%
paraformaldehyde (PFA) for 1 h and washed with phosphate-
buffered saline (PBS).
Cryosection of Rat Cerebella (p6, p17, p30)
Cryosection of rat cerebella were obtained from p6, p17 and
p30 Wistar rats. After decapitation and dissection of the brain,
p17 and p30 rats were fixed with 4% PFA. Cerebella were
then isolated and post fixated with 4% PFA at 4◦C overnight.
After PBS washing, cerebella were transferred to 30% sucrose
for 2 days. Afterwards, they were deep-frozen in isopentane
at −50◦C. Samples for cryosectioning were fixed with tissue
freezing medium (Leica) and cut on a cryostat (Leica CM
3050 S; chamber and stage temperature of −18◦C and −20◦C
respectively). Cryosections (40 µm thick) were applied on glass
slides (J1800AMNZ, Menzel-Gläser, Braunschweig, Germany).
In Situ Hybridization
Surgical procedures and cryosections (15 µm) of rat cerebella
were obtained from p6 and p30 Wistar rats under sterile
RNase-free conditions as described in Pieczora et al. (2016).
All solutions were prepared with DEPC-treated water. In situ
hybridization was performed according to the instruction
manual ‘‘FFPE in situ hybridization using double-labeled
Fluorescein or DIG miRCURY LNATM microRNA Detection
probes’’ (Exiqon). Briefly, the cryosections were incubated in
4% PFA at room temperature for 15 min. After washing 3×
3 min with PBS the slides were incubated with 20 µg/ml
proteinase K (microRNA ISH Buffer Set #9000; Exiqon) for
10 min at 37◦C. For hybridization the tissue was incubated
with 80 nM of double DIG-LNATM mRNA probe (VEGFR-
2 custom LNA mRNA detection probe, Exiqon) probe diluted in
microRNA ISH Buffer (#9000, Exiqon). The tissue was incubated
for 2 h at 54◦C. Afterwards the tissue was washed once with
5× SSC for 5 min, respectively twice with 1× SSC and 0.2× SSC
for 5 min at hybridization temperature and finally with once
with 0.2× SSC for 5 min at room temperature. To visualize the
probe the slides were incubated for 1 h with anti-Digoxigenin
Alkaline Phosphatase, fab fragments (sheep, 1:800, 11093274910;
Roche). Meanwhile a NBT-BCIP tablet (11697471001; Roche)
was dissolved in DECP-water, adding Levamisol (31742; Fluka)
at the end. The AP substrate was incubated for 90 min in the dark
at room temperature. Finally the tissue was incubated with 150µl
Nuclear Fast Red (N3020; Sigma-Aldrich) per slide for 1 min,
washed, dehydrated and fixed with mounting medium. The
tissue was stored over night at room temperature and analyzed
by light microscopy (Olympus BX 61) the subsequent day.
Immunohistochemistry
p1 Rat Cerebellar Slice Cultures (Group 1 + 2)
After cultivation of the cerebellar slice cultures for the
appropriate time the slices were fixed in 4% PFA in PBS for 1 h
and rinsed with PBS. To block non-specific binding sites and to
permeabilize the cell membrane a solution of 10% goat serum
(G9023; Sigma-Aldrich) and 0.2% Triton-X-100 (T8532; Sigma-
Aldrich) in PBS was added for 90 min, followed by incubation
with primary anti-calbindin-D28K antibodies (rabbit, 1:1000,
C2724; Sigma-Aldrich) to label specifically PCs. In neonatal PCs
(group 1) antibodies were diluted in 0.2% Triton-X-100 and 1%
goat serum in PBS, and placed in a fridge (4◦C) for 2 days.
After washing with PBS, secondary anti-rabbit Alexa Fluor
488 antibodies (goat, 1:400, A11008; Molecular Probes) were
used in 0.1% Triton-X-100 and 1% goat serum in PBS were
applied overnight at 4◦C. Juvenile PCs of group 2 were stained
with anti-calbindin-D28K antibodies (mouse, 1:200, L9848;
Sigma-Aldrich) diluted in PBS containing 0.1% Triton-X-100
and 1% goat serum were applied overnight at 4◦C. After several
washing steps with PBS, secondary anti-mouse IgG TRITC
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(goat, 1:200, T5393; Sigma-Aldrich) antibodies, which had been
dissolved in 0.1% Triton-X-100 and 1% goat serum in PBS, were
applied for 3 h. After intensive washing, nuclear counterstaining
was done with bisBenzimide Hoechst 33342 trihydrochloride
(1:1000, B2261; Sigma-Aldrich) for 20 min. Finally, cell cultures
were rinsed with PBS and embedded in fluorescence mounting
medium under a coverslip (S3023; Dako).
p6, p17 and p30 Cerebellar Rat Cryosections
After blocking and permeabilization, cryosections were
incubated with primary antibodies against VEGFR-2 (rabbit,
polyclonal, 1:100, ab39256; Abcam) and placed in a fridge (4◦C)
overnight. After washing with PBS, secondary FITC-coupled
anti-rabbit IgG (goat, 1:400, F6005; Sigma Aldrich) or Alexa
Fluor 488-coupled anti-rabbit IgG (goat, 1:400, A-11008,
Molecular Probes) antibodies were added overnight at 4◦C.
Nuclear counterstaining was done with bisBenzimide Hoechst
33342 trihydrochloride (1:1000, B2261; Sigma-Aldrich). Further
steps of immunohistochemistry were done in the same manner
as just described (group 1 + 2) to label PCs.
Microinjection (Group 2 + 3)
With aid of the microinjection technique yellow fluorescent
protein-actin plasmids (pEYFP-actin; 0.195 µg/µl; custom
made) were injected into single juvenile (group 2) and mature
(group 3) PC cell nuclei of cerebellar slice cultures. Either sterile
glass capillaries (diameter: 0.2–0.5 µm, Femtotips; Eppendorf,
Germany) or capillaries (Hilgenberg, Nr. 1403512, Germany;
borosilicate glass: 1.5 mm/0.2 mm; Puller: Sutter Instruments
P97, USA) were filled with 2 µl of plasmid solution. Using an
inverted microscope equipped with long-distance phase-contrast
optics (Axiovert 35, Zeiss, Germany), PCs were imaged in slice
cultures. During microinjection cultures were kept at 37◦C on
a heating stage. Application settings of the pressure injection
devices (InjectMan NI2 and FemtoJet; Eppendorf) were set to
inject with 80 hPa for 0.5s The constant pressure was defined
as 60 hPa. After microinjection, nutrient medium was replaced
carefully and slice cultures then further incubated for at least 24 h
to receive a sufficient signal.
Morphometric Analysis
Dendritic Length of Neonatal and Juvenile PCs
(Group 1 + 2)
To investigate the effect of VEGF on neonatal and juvenile
PCs, morphometric analysis of group 1 and 2 were performed
with four different experimental conditions. All slices were
cultured for 5 div (group 1) or for 16 div (group 2). The
control group was incubated without any addition of VEGF
or axitinib. In the other groups VEGF, VEGF + axitinib or
solely axitinib were added during the last 2 days of incubation.
Thereafter morphometric analysis was done with confocal laser
scanning microscopy (CLSM; Axiovert 100M, LSM 510 meta;
Zeiss) in combination with oil immersion lenses (Plan-Neofluar
40x/1.3 Oil, Zeiss; resolution x: 0.22 µm, y: 0.22 µm, z: 0.26 µm).
With the aid of the Zeiss physiology kit, every single dendrite
of the PCs was measured, and each distance was added together
to give the total dendritic length. To determine morphometric
changes measured data of the control group were defined as
100% whereby the changes were calculated. Statistical analysis of
the impact of VEGF on neonatal and juvenile PC morphology
was performed with 320 PCs from a pool of at least 25 rat
cerebella.
Dendritic Spreading, Dendritic Length and Cell Soma
Area of Juvenile and Mature PCs
To examine the impact of VEGF on the dendritogenesis of
juvenile and mature PCs, morphometric analysis of group 2 and
3 were performed after exposure to different experimental
conditions. After microinjection of pEYFP-actin into PCs of
group 2 and group 3, CLSM was done (Plan-Neofluar 20x/0.5;
Zeiss; resolution x: 0.22 µm, y: 0.22 µm, z: 1.3 µm). Control
slices were cultured without the addition of VEGF or axitinib.
The other slice cultures were cultured with VEGF (group 2 + 3),
VEGF + axitinib (group 2) or solely axitinib (group 2) for 48 h.
Thereafter the same PCs were studied (n = 20 per condition).
Using the Zeiss physiology kit, dendritic length was measured
as described before. Circumference of the dendritic arbor and
cell soma area were measured by manual encircling, with the
measured changes quoted as percentages. Statistical analysis of
the impact of VEGF on juvenile and mature PC morphology
was performed with 120 PCs from a pool of at least 80 rat
cerebella.
Quantitative PCR (qPCR)
Surgical Procedures/Cryosection for Laser
Microdissection
Surgical procedures and cryosections of rat cerebella were
obtained from p6 and p30 Wistar rats under sterile RNase-free
conditions as described in Pieczora et al. (2016). After
decapitation and dissection of the brain, cerebella were isolated
and frozen at −50◦C in isopentane and stored at −80◦C. For
affixing the tissue to the cryostat (Leica CM 3050 S), a minimal
amount of freezing medium (Leica) was used. Samples were
cut at a thickness of 10 µm, placed on glass slides coated with
polyethylene napthalate (PEN; 11505189; Leica) and stored at
−80◦C.
Cresyl Violet Staining
After being left to thaw at room temperature, the slides were
placed in 70% p.a. ethanol for 2 min followed by incubation in
1% cresyl violet solution in 50% p.a ethanol for 30 s. Sections
were then dehydrated first in 70% p.a. ethanol several times and
then in 100% p.a. ethanol for 10 s. Finally, the slides were dried
at room temperature. All solutions were diluted in DEPC-treated
water.
Laser Microdissection
Laser microdissection was performed with a PALM Micro
Beam instrument (P.A.L.M.-System LCM, Carl Zeiss Microscopy
GmbH) with non-adhesive tubes (MicroTube 500, Carl Zeiss
Microscopy GmbH) as described previously by Molina et al.
(2015). In brief, laser microdissection was done with 10 µm-
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thick cresyl violet stained cryosections. The optimal thickness
was based on the ability to catapult the regions of interest
after laser-cutting. These regions were visualized in the tissue
sections and marked for the laser beam within the software
provided with the instrument. The non-adhesive tube (filled
with 50 µl of lysis buffer, Z6010, Promega) was placed
over the section and laser microdissection was performed. In
total about 3000 PCs were collected. Afterwards, the tube
was closed and stored upside-down at −80◦C until further
usage.
RNA Isolation and qPCR
Total RNA was extracted from PC-enriched samples (around
3000 laser microdissected cells), initially filled up to 300 µl lysis
buffer (Z6010, Promega), using ReliaPrepTM RNA Cell Miniprep
System (Z6010, Promega). Briefly, cells were homogenized in
300 µl lysis buffer with 2% 1-Thioglycerol added. Nucleic acids
were bound to ReliaPrepTM Minicolumns by centrifugation.
For removal of genomic DNA an on-column DNAse digestion
was performed according to manufacturer’s description. Total
RNA was eluted with 15 µl nuclease free water and frozen
at −80◦C for storage. cDNA synthesis was performed using
Reverse Transcription System (A3500, Promega) according
to manufacturer’s protocol using 1 µg total RNA and
Oligo(dT)15 Primers. Reactionmixture was incubated for 60min
at 42◦C and stopped by heating the sample at 95◦C for
5 min following an incubation at 4◦C for 5 min. cDNA was
stored at −20◦C until use. Standard quantitative PCRs were
performed on a CFX96 Real Time PCR Detection System
(BioRad) using GoTagr qPCR Master Mix (A6001, Promega)
according to manufacturer’s recommendation. Melting curves
were obtained after each PCR run and showed single PCR
products. Expression levels for the genes of interest and for
housekeeping geneGAPDH were measured in three independent
PCR runs. Fold change of expression was calculated using
the 2−∆∆Ct method. The relative expression levels of validated
mRNAs were compared using an unpaired two-tailed t-test.
In order to visualize the purity of microdissected PCs, the
relative mRNA amount of the marker genes was expressed
as a percentage. We added the relative means of all marker
genes and defined the amount as 100%. We were then able
to generate the relative amount by calculating the ratio of
the marker genes compared to the total relative amount of
mRNA (Pieczora et al., 2016). Primer sequences used were:
KDR (codes for VEGFR-2): (5′-TCC CAG AGT GGT TGG
AAA TG-3′, 3′-ACT GAC AGA GGC GAT GAA TG-5′,
Microsynth); FLT1 (codes for VEGFR-1): (5′-GTG AAG AGT
GGG TCG TCA TTC-3′, 3′-CTA TGG TTT CCT GCA CCT
GTT-5′); GAPDH: (5′-ACT CCC ATT CTT CCA CCT TTG-
3′, 3′-CCC TGT TGC TGT AGC CAT ATT-5′, Microsynth).
To analyze distinct mRNAs in microdissected PCs we compared
different neuronal marker genes. The following primers were
used: calbindin (5′-GAA GGA AAG GAG CTG CAG AA-3′,
5′-TCT GCC CAT ATT GAT CCA CAA A-3′, Microsynth),
GFAP (5′-GAG TGG TAT CGG TCC AAG TTT-3′, 5′-TTG
GCG GCG ATA GTC ATT AG-3′, Microsynth), NeuN (5′-
GAG AAG CTC AAT GGG ACG AT-3′, 5′-CAT ATG GGT
TCC CAG GCT-3′, Microsynth), TNFα (5′-GCT CCC TCT
CAT CAG TTC CA-3′, 5′-GCT ACG GGC TTG TCA CTC-3′,
Microsynth), α6GABAa-R (5′-CCG ATG AGA CTG GTT AAC
TTC C-3′, 5′-TCT TCT GGG ACC TCT ACT GAA T-3′,
Microsynth), VGlut1 (5′-CCT GCG CAG TCG TCA TAT
AAT-3′, 5′-GCCCTTGGAGTGTGAGTATC-3′, Microsynth),
and GAPDH (5′-ACT CCC ATT CTT CCA CCT TTG-3′,
5′-CCC TGT TGC TGT AGC CAT ATT-3′, Microsynth).
For statistical analysis, Microsoft Excel and Graph Pad Prism
were used.
RESULTS
Morphometric Analysis of PCs After VEGF
Treatment
In our study we examined the effects of VEGF on neonatal,
juvenile and mature PCs in cerebellar roller tube slices.
The functionality of PCs in slice cultures was proven in
former studies by analysis of axonal transport and functional
synapses (Krah and Meller, 1999; Wessel et al., 2014). With
aid of immunohistochemistry and CLSM our first aim was
to analyze cerebellar roller tube slices in regard to their
organotypic structure. Therefore, various incubation times of
cerebellar slices of p1 and p9 pups were compared with
cerebella cryosections of p6, p17 and p30 rats (Figures 1A–F,
2A–F).
At birth cerebellar structures are still immature, with a
characteristic external granule cell layer (eGCL) above the
molecular cell layer (MCL). In cryosections of p6 rat cerebella,
and in cerebellar slice cultures of p1 rats cultured for 5 days,
the fourth layer (eGCL) still exists (Figures 1A,D). At this
early stage PCs are distinguished by multiple short perisomatic
dendrites (Figures 2A,D). At this point of time granule cells
GCs migrate from the eGCL through the MCL and Purkinje
cell layer (PCL) to generate the inner granule cell layer (GCL),
with its migration peak at p10-11 (Altman, 1972; Kunimoto and
Suzuki, 1997), and its end after 16 days of maturation (Mancini
et al., 2009). Thus, cryosections of p17 rat cerebella show the
three-layered cerebellar cortex with a band of PCs, which is
quite similar to the slice cultures of p1 rats incubated for 16 div
(Figures 1B,E). At these juvenile stages, PCs contain one or two
stem dendrites covered with a moderate number of dendritic
spines (Figures 2B,E).
Matured cerebellar slices of p9 rats followed by 21 div also
displayed the typical three-layered cerebellar cortex structure,
which is comparable to the morphology of cryosections of
p30 rats, characterized by a thick MCL with prominent
dendritic arbors of the PCs. Cell bodies of PCs are arranged,
as a clear band in the PCL, and densely packed GCs are
located in the innermost GCL (Figures 1C,F). At this mature
stage, the impressive dendritic arbor arises from the stem
dendrites ramified with two or three main, and multiple
smaller dendritic branches, with numerous dendritic spines
attached to them (Figures 2C,F). Thus, the roller tube slices
represent a functional and compact organotypic cerebellar
cortex, which can be cultivated for several weeks. It is highly
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FIGURE 1 | Cerebellar cortex structure in cryosections and organotypic slice cultures. (A–C) Cryosections: p6, p17, p30; (D–F) cerebellar slice cultures:
p1 + 5 div, p1 + 16 div, p9 + 21 div. (A) In p6 cryosection and (D) p1 + 5 div cerebellar cultures calbindin-positive Purkinje cells (PCs; red) and cell nuclei (blue) display
the four-layered cortex structure of the cerebellum. Extragranule cells (eGC) form the outermost cell layer called the external granule cell layer (eGCL). In the juvenile
stage at p17, eGC migration has finished and the typical three-layered structure of the cerebellar cortex can be seen in cryosections (B) and cerebellar slice cultures
(E). (C,F) In mature PCs, dendritic trees extend into the thick molecular cell layer (MCL), while the Purkinje cell layer (PCL) is characterized by the line-shaped
arrangement of PC somata. Also, in the organotypic slice cultures, the three-layered structure of cerebellar cortex is still well retrained. Scale bars: 100 µm.
suitable for obtaining a deeper insight into the mechanism of
VEGF-effects on PCs of the cerebellum when concerning their
maturation.
VEGFR-2 Expression in the Cerebellum
Focusing on Neonatal, Juvenile and
Mature PCs
To determine any impact of VEGF on PC morphology, which
is likely to be mediated through an interaction with VEGFR-2,
expression of this receptor was verified in neonatal, juvenile
and mature PCs (p6, p17, p30) in the cerebellum. Therefore,
the methods of immunohistochemistry, and additionally laser
microdissection with qPCR were used.
An intense signal of the VEGFR-2 antibody was
detectable in neonatal PC cell bodies and dendrites as well
as in Bergmann glia fibers, along with a diffuse signal
in the eGCL, MCL and inner GCL (Figures 3A–C). In
the PCL and MCL of juvenile p17 rat cerebella, positive
VEGFR-2 labeling degraded in PC dendrites and cell somata
(Figures 3D–F). In p30 rat cerebella with almost mature PCs,
positive VEGFR-2 signals were hardly observed in the PCL
(Figures 3G–I).
In order to examine the expression of VEGFR-2 mRNA in
PCs at the age p6 and p30 we performed in situ hybridization
using a specific VEGFR-2 double DIG-LNATM mRNA probe
(Exiqon). We detected a high expression of VEGFR-2 mRNA
in very young PCs (Figure 4A). The PCL could be visualized
very distinct by labeling the cell bodies and dendrites of neonatal
PCs, located between the MCL and inner GCL. In p30 rat
cerebella positive VEGFR-2 labeling was hardly detectable,
(Figure 4B). Additionally we could reveal a positive signal
in the eGCL and inner GCL in p6 rat cerebella as well as
in the GCL at the stage p30. These findings demonstrate
that VEGFR-2 expression extremely decreases during PC
development and correspond with the results presented by
immunohistochemistry.
Via the qPCR method, mRNA expression of KDR, that
codes for VEGFR-2, was detected in microdissected PC-enriched
samples of very young and mature stages (Figure 4C). Gene
expression values for p6 were set to 100%. At p30 the
expression level of KDR mRNA was decreased to only 28%
(Figure 4D). Additionally we analyzed the expression of the
VEGFR-1 encoding FLT1 gene in p6 and p30 rat cerebella,
setting KDR gene expression values for p6–100%. In p6 and
p30 the expression of FLT1 mRNA did not significantly
change in young and mature PCs, the ratio amounted less
than 5% (Supplementary Figure 1). Thus, laser microdissection
followed by qPCR, as well as immunohistochemistry, underline
that VEGFR-2 is expressed in PCs during their entire
development, albeit with a significant decrease in mature
stages.
To ensure that the VEGFR-2 expression is highly unique
for PCs, we performed a qPCR with specific marker genes
for PCs, Bergmann glia, microglia and GCs. The amount
of contamination from cells other than PCs is extreme low
(Figures 4E,F). At the age of p6, calbindin (a specific marker
for PCs) amounts to 93.6 ± 1.2% and 90.3 ± 1.1% in
p30 rat cerebella. Nevertheless, a slight contamination with
neuronal and glial marker can be observed. In rat cerebella
at stage p6 the relative amount of GFAP expressed mRNA
is 5.3 ± 0.08%, 3.41 ± 0.05% in p30. Furthermore the
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FIGURE 2 | Changes of PC morphology in cryosections and slice cultures during development. (A–C) Cryosections: p6, p17, p30; (D–F) cerebellar slice
cultures: p1 + 5 div, p1 + 16 div, p9 + 21 div. (A) In early development calbindin-positive PCs labeled with red fluorescent secondary antibody display a bipolar shape
with perisomatic pre-dendrites. (B) During maturation, PCs show main and secondary dendrites until single tertiary branches can be detected at p30 (C). These
matured PCs are characterized by highly ramified dendritic arbors that are covered by numerous dendritic spines. In addition, in organotypic cerebellar slice cultures
the development of PCs is very similar, as the dendritic arbor expands during development (D–F). Scale bars: (A,D) 10 µm (B,E) 20 µm (C,F) 30 µm.
contamination of gene markers for NeuN is 0.46 ± 0.01%
in young rat cerebella and 0.83 ± 0.01% in p30. For TNFα
the contamination is in the range of 0.1 ± 0.01% in p6 and
0.14 ± 0.01% in p30, for α6GABAa-R it is 0.54 ± 0.01% and
VGlutI is 1 ± 0.01% at the age of p6. At the age of p30 the
contamination for α6GABAa-R is 3.7 ± 0.02% and VGlut1
0.02± 0.01%.
Impacts of VEGF on Dendritic Length,
Circumference of the Dendritic Arbor and
Cell Soma Area of PCs
VEGF Increases Dendritic Length of Neonatal PCs
In order to visualize the effect of VEGF on neonatal PCs
(group 1), cerebellar slice cultures were incubated with VEGF
after 3 div for further 48 h. Besides VEGF treatment, VEGF +
axitinib, or solely axitinib, were added. As controls, slices without
any additive component were cultured for 5 div. Subsequently
these cultures were subjected to immunohistochemistry. The
length of all dendrites of one calbindin-positive PC was summed
in at least 40 PCs per condition as described in Wessel
et al. (2014). Here, in comparison to PC dendrites of control
slices (total dendritic length averages around 83 ± 2 µm),
VEGF exposure induced a significant increase in the total
dendritic length of averaging 100 ± 3 µm (p < 0.0001;
Figures 5A,B). Incubation with axitinib, which inhibits signaling
pathways of VEGF-receptors such as the VEGFR-2, led to a
significant reduction in the total dendritic length to 68 ± 1 µm
(p < 0.0001) compared to the control (Figure 5C). After
incubation with a mixture of VEGF plus axitinib, a significant
reduction in the total dendritic length to 74 ± 2 µm
was perceived in comparison to the control (p < 0.05;
Figures 5D,E).
Thus, neonatal PCs are susceptive and sensitive to VEGF
in general. It is known that physiological levels of VEGF are
necessary for an undisturbed dendritogenesis process in the
cerebellum, whereas experimental VEGF addition is capable of
promoting and enhancing dendritogenesis of neonatal PCs. As
VEGF effects were reduced by axitinib in neonatal PCs,
here it is likely that the impact is mediated through signal
cascades of VEGF-receptors. However, as the combination
of VEGF + axitinib leads to a slightly obvious increase,
dendritogenesis may also be driven by non-axitinib-sensitive
pathways.
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FIGURE 3 | Vascular endothelial growth factor receptor 2 (VEGFR-2) expression in cerebellar p6, p17 and p30 rats. (A-I) Immunostaining of calbindin
positive PCs (red), VEGFR-2 (green) and cell nuclei (blue) in cryosections of rat cerebella at p6, p17, p30. VEGFR-2 receptors are localized within the soma (simple
white arrowheads; A–I) of PCs and in Bergmann glia fibers (white arrows; B), reaching up to the MCL; exemplarily few cell nuclei are labeled in different cell layers
(curved white arrowheads; B,C,E,F,H,I). Scale bars: (A–I) 20 µm.
VEGF Increases Dendritic Length, Dendritic Tree
Spreading and Cell Soma of Juvenile PCs
To investigate the effects of VEGF on juvenile PCs (group 2),
cerebellar slice cultures were cultured for 16 div as controls,
or for 14 days and then subjected to VEGF, VEGF + axitinib
or axitinib treatment for another 2 days. The total length of
immunostained PC dendrites were measured and summed to
get the total dendritic length (n = 40 PCs per condition).
A significant increase in the dendritic length to 349 ± 11 µm
(p < 0.0001) was measured under VEGF treatment conditions
compared to the control (269 ± 10 µm; Figures 6A,B).
Incubation with solely axitinib or VEGF + axitinib did not lead
to any significant changes of the dendritic length (Figure 6C).
However, after axitinib, or VEGF plus axitinib incubation,
PCs showed a significant total dendritic length reduction to
243 ± 10 µm or 274 ± 8 µm in comparison to VEGF
treated PCs (p < 0.0001). Thus, VEGF also has the capability
to enhance dendritogenesis at the juvenile stage. Besides this,
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FIGURE 4 | mRNA expression levels in PCs. (A,B) In situ hybridization: expression of VEGFR-2 in rat cerebella at the age of p6 (A) and p30 (B). Cryosections
(15 µm) of each stage were incubated with 80 nM double-DIG-LNATM probe (Exiqon). In p6 nearly every PC showed a positive VEGFR-2 signal. During development
the expression of VEGFR-2 extremely decreases. In p30 VEGFR-2 positive PCs were hardly detectable. P6 and (C) p30 PCs were laser microdissected at 200×
magnification and subjected to the method of quantitative polymerase chain reaction (qPCR) (D). For relative quantification of KDR expression, the 2−∆∆Ct method
was conducted using the housekeeping gene GAPDH for normalization; data are provided as means ± SEM. Data were tested for significance using
(Continued)
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FIGURE 4 | Continued
Student’s t-test. Significant differences are indicated by ∗∗∗p < 0.0001; n = 3.
(E,F) Expression of specific markers in microdissected PCs in rat cerebella at
the age of p6 (E) and p30 (F) using qPCR, normalized to GAPDH. Relative
expression of mRNA markers was compared by using an unpaired two-tailed
t-test. These values were summed up and defined as 100%. The ratio of each
marker mRNA was compared to the total relative expression of mRNA. This
reveals a slight contamination in microdissected PCs with surrounding cells.
(∗∗∗p < 0.0001). Scale bars: (A,B) 100 µm (C) 50 µm.
single PCs of group 2 were microinjected with pEYFP-actin
(Figures 6D,E). After the microinjection, individual PCs could
be analyzed by CLSM before they were treated with VEGF,
VEGF + axitinib or solely axitinib for another 2 days. As only
individual PCs are labeled with the aid of this microinjection
technique, we could identify and capture the same PC after
treatment to analyze different parameters as the total dendritic
length, the dendritic tree spreading and the cell soma area
again (n = 20 PCs per condition). The huge advantage of
this method is that identical cells are examined before and
2 days after experimental treatment. After 48 h of incubation
untreated cells served as controls and were equated with 100%.
VEGF treatment induced significant increases in the total
dendritic length (15 ± 4%, p < 0.001), in the circumference
of the dendritic arbor (22 ± 3%, p < 0.001) and in the
cell soma area of 14 ± 2% (p < 0.001; Figures 6D–F).
Compared to control, axitinib incubation resulted in a significant
reduction in total dendritic length (−7 ± 2%, p < 0.05),
and in circumference of the dendritic arbor (−9 ± 3%,
p < 0.05), whereas changes in cell soma area were not
significant. Growth parameters of VEGF plus axitinib-treated
PCs showed a slight but not significant decrease in all parameters
(Figure 6F).
Thus, with the aid of pEYFP-actin staining, our study
underlines the capability of VEGF to enhance dendritogenesis
in juvenile stages, probably through interaction with VEGFR-2.
Remarkably, VEGF exposure induced an increase of cell soma
area, although physiological cell soma growth has nearly finished
at this point of time.
VEGF has no Impact on Dendritogenesis in
Mature PCs
To investigate the effects of VEGF on matured PCs (group 3)
in cerebellar slice cultures, pictures of native pEYFP-actin
microinjected PCs were captured with the aid of CLSM.
Subsequently, these cultures were incubated with or without
additional VEGF for 2 days. The same PCs were imaged again
and analyzed in regard to their length growth parameters as
described above. In the control group, no significant changes
were measured either in the total dendritic length, circumference
of the dendritic arbor or in the cell soma area after 2 days of
incubation. Additional VEGF exposure did not promote any
significant increase in dendritic length, circumference of the
dendritic arbor or cell soma area (Figure 7). Thus, at this point
in time the maturation of the PC dendritic tree and cell soma has
finished, and VEGF is not capable to induce dendritogenesis and
somatogenesis in mature PCs.
DISCUSSION
After the initial description of VEGF as a tumor-secreted vascular
permeability factor (Senger et al., 1983), the understanding of
VEGF functions in mammalian species expanded rapidly from
their central role in angiogenesis and vasculogenesis, to their
acceptance as a neurotrophic factor. Despite the increasing
scientific and therapeutic interest in VEGF, information
on its effects in the central nervous system (CNS) is
still limited. The influences of VEGF on neurons of the
cerebellum were already the subject of different studies such
as in granule cell migration (Ruiz de Almodovar et al.,
2010). However, only sparse and incomplete information are
available about the impact of VEGF on PC development
and maturation. Furthermore, the mechanisms of VEGF
receptor signaling within PCs are still incomplete. Thus, in
the present study, effects of VEGF on neonatal, juvenile
and mature PCs were analyzed in organotypic cerebellar
roller-tube slice cultures, and additionally VEGFR-2 distribution
on PCs was verified. Consequently, VEGF effects on PC
dendritogenesis and somatogenesis were determined to be
mediated through molecular mechanisms of VEGFR-2 signaling
pathways.
Neonatal, Juvenile and Mature PCs
Express VEGFR-2
The impact of VEGF in the nervous system is more and
more becoming an investigative focus, so that VEGF-receptor
expression in the peripheral nervous system (PNS) and CNS
has been investigated in several studies. Many VEGF effects
are mediated through VEGFR-2 (Zachary, 2005; Carmeliet
and Ruiz de Almodovar, 2013) and this receptor expression
was detected in neuronal tissues of the forebrain, in the
hippocampus (Yang et al., 2003; Fournier et al., 2012), but
also in the subventricular zone and olfactory bulb (Maurer
et al., 2003), and in the temporal cortex (Boer et al., 2008).
Licht et al. (2011) assumed the possibility of low levels of
VEGFR-2 expression in non-endothelial cells, confirmed by the
verification of VEGFR-2 expression in for example glia cells
as astrocytes or Bergmann glia (Ruiz de Almodovar et al.,
2010; Wuestefeld et al., 2012). Here, low levels of VEGFR-2
expression were detected in adulthood (Kremer et al., 1997;
Matsuzaki et al., 2001; Cui et al., 2010). In line with this,
a decrease of VEGF and VEGFR-2 levels in the cerebellum
was underlined in a former study, which demonstrated that
perikarya of PCs had a positive VEGFR-2 signal during gestation,
but 13 months postnatal no VEGFR-2 signal was detectable
anymore (Sentilhes et al., 2010). Another study showedVEGFR-2
expression in PCs of very young primary cerebellar slice
cultures of mice by immunohistochemistry, and additionally
they also detected VEGFR-2 expression in cryosections of mice
cerebella with aid of quantitative RT-PCR (Cvetanovic et al.,
2011).
In the present study, these results could be confirmed
with the detection of VEGFR-2 expression in rat PCs by
immunohistochemistry and in situ hybridization. Here a strong
positive receptor signal was detected in the young developmental
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FIGURE 5 | Morphometric analysis of VEGF effects on neonatal PC dendrites. (A) Analysis of young, calbindin-stained PCs (labeled with green fluorescent
secondary antibody, p1 + 5 div), and treated with VEGF (B), axitinib (C) or VEGF + axtinib (D) for a period of 48 h. (E) Morphometric analysis of the dendritic length.
Data are provided as means ± SEM. Data were tested for significance using one-way ANOVA with Bonferroni multiple comparisons post-test. Significant differences
are indicated by ∗∗∗p < 0.0001, ∗p < 0.05; n = 40. Scale bars: 10 µm.
stages, with a significant reduction of VEGFR-2 protein. Using
laser microdissection, followed by qPCR we demonstrated
the reduced expression level of VEGFR-2 mRNA in mature
stages and an unchangeable low expression level of VEGFR-1.
Based on the hardly detectable VEGFR-1 amounts it might
be assumed that the impact of VEGF on young cerebellar
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FIGURE 6 | Morphometric analysis of VEGF effects on juvenile PC dendrites and cell somata. (A) Analysis of the total dendritic length of calbindin-stained
PCs (red; p1 + 16 div), or PCs incubated with VEGF (B), VEGF + axitinib or axitinib for a period of 48 h. (C) Morphometric analysis of the dendritic length. Data are
provided as means ± SEM. Data were tested for significance using one-way ANOVA with Bonferroni multiple comparisons post-test. Significant differences are
indicated by ∗∗∗p < 0.0001; n = 40. Scale bars: 10 µm. Besides morphometric analysis of the total dendritic length (one dendrite is exemplarily labeled in red),
circumference of the dendritic arbor and cell soma area (blue encircled) of pEYFP-actin microinjected PCs (green) before (D) and after 48 h drug incubation (E) are
analyzed. (F) Changes in morphometric parameters for controls and treated cells are given in percent; data are provided as means ± SEM; n = 20. Untreated
(Continued)
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FIGURE 6 | Continued
neurons were defined as control (100%) and treated cells were normalized to
this control. Scale bars: 20 µm. Data were tested for significance using
one-way ANOVA with Bonferroni multiple comparisons post-test. Significant
differences are indicated by ∗∗∗p < 0.0001, ∗p < 0.05; n = 20. Scale bars:
20 µm.
PCs is most likely mediated by VEGFR-2; no visible effects
on mature PCs would go along with the results of IHC and
qPCR. To ensure the observed effects ascribe to age-dependent
expression levels of VEGFR-2 in PCs, the mRNA level of
neuronal and glial markers were analyzed in microdissected
PCs. The cerebellar cortical tissue is organized very densely.
PCs are surrounded by several cell types such as Bergmann glia
(Verkhratsky and Reichenbach, 2010). A slight contamination
of microdissected PCs with these cells is inevitable. We were
able to detect calbindin, a specific marker for PCs, as the vast
majority component in our microdissected samples (Baimbridge
et al., 1992). Furthermore, we could exclude contamination
with immunoactive microglial cells as the mRNA expression
level of TNFα was hardly detectable, indicated the absence of
microglial cells (Deng et al., 2008; Kaur et al., 2014). Besides
this, contamination with other cerebral cell types could be
excluded. The expression level of NeuN, a marker for neuronal
cells of the CNS (Mullen et al., 1992), was extreme low as well
as the expression levels of α6GABAa-R and VGlut1 mRNA.
These findings underlined former studies which disproved
the presence of α6GABAa-R and VGlut1 within the PCL in
rodents. (Fremeau et al., 2001; Wojcik et al., 2004; Hörtnagl
et al., 2013). The samples of microdissected PCs showed a
very low amount of contamination with cells surrounding PCs.
Additionally, these results reveal another important fact: the
extremely low levels of GFAP and NeuN mRNA in p6 and
p30 PCs, indicating a negligible impact of VEGFR-3. VEGFR-3
is upregulated in glial cells and strongly associated with the
expression of GFAP and NeuN (Shin et al., 2008; Ward and
Cunningham, 2015). Recently it could be shown that GFAP
was highly expressed at the age of p15 in rats, accompanied
with high expression of VEGFR-3. In the neonatal period
the expression of NeuN and VEGFR-3 showed a comparable
expression pattern (Ward and Cunningham, 2015). In our study
the expression of glial and neuronal markers in microdissected
PCs could be disproved in both examined stages. The purity
of the microdissected samples as well as the closely connected
expression of glial and neuronal markers with VEGFR-3
expression allows us to discuss the higher levels of VEGFR-2
in p6 compared to p30 in a developmental context (Brown
et al., 2013; Sugino et al., 2015; Ward and Cunningham,
2015).
VEGF Influences Neonatal and Juvenile PC
Development in Cerebellar Slice
Cultures—No Effects are Detectable in
Mature PCs
Two to three days before birth, after PC-migration has stopped,
PCs exhibit a bipolar fusiform shape that changes into a
stellate shape with perisomatic predendrites. After a short
retraction phase, main branches are established and the definitive
polarity of these neurons is established (Armengol and Sotelo,
1991; Sotelo and Dusart, 2009). Our slice cultures of group 1
and group 2 were examined as representatives of an early
developmental stage. Through the method of microinjection
and immunohistochemistry it was possible to label PCs in
organotypic cerebellar slice cultures and measure the total
dendritic length, circumference of the dendritic arbor and soma
size in different developmental stages. As it is impossible to
microinject PCs in the cerebellar slices at the neonatal stage,
here, solely the method of immunohistochemistry was used to
investigate dendritogenesis. The present results demonstrate for
the first time a significant increase in the total dendritic length of
very young PCs after VEGF addition compared to control slice
cultures.
Remarkably, in the prolonged maturation process of
dendritogenesis and somatogenesis in PCs, VEGF also seems
to be a growth factor for dendrites and cell somata. At this
point in time, direct quantification of VEGF-induced changes
or changes due to VEGF receptor inhibition on PC morphology
was performed through the precise method of microinjection
and immunohistochemical analysis. Significant additive effects
in all growth parameters were measured under VEGF exposure,
so that PC dendritogenesis is most likely enhanced in neonatal
and juvenile stages. Therefore, together with NT3, BNDF,
NGF, BMP7, Reelin or T3 VEGF is another highly potential
stimulating and enhancing factor of dendritogenesis (Miller
and Kaplan, 2003; Boukhtouche et al., 2010; Castagna et al.,
2014). The effects of direct exogenous VEGF application on
developing PC dendritogenesis were not yet analyzed. However,
Cvetanovic et al. (2011) examined whether replenishing VEGF
improves the SCA1 phenotype in mice by using clinically
affected animals, which overexpressed human VEGF. Thereby,
an enhancement of Rotarod performance was measured
and a generally better outcome of SCA1 mice was detected,
which underlined promoting and protective effects of VEGF
on PCs.
Earlier studies revealed that after the initial 30 days
development period, PCs reached their mature dendritic shape
with tertiary dendritic branches, with no further quantitative
changes detected (Altman, 1972; Berry and Bradley, 1976; Sotelo
and Dusart, 2009). Our data support this, as PCs of control slice
cultures did not reveal any significant changes in dendritic length
or cell soma size after 48 h of incubation, indicating that PC
growth apparently finished in this mature phase. For therapeutic
targets, our study examined PCs of this age to gain new insight
into the impact of VEGF after the maturation process. Here, no
significant increase on PC dendritogenesis and somatogenesis
was detected after VEGF administration. Thus, our data indicate
that VEGF effects on PC dendritogenesis and somatogenesis
are age-dependent and are restricted to immature PCs, whereas
mature PC dendrites and somata are not susceptible to VEGF
anymore. This downregulation of VEGF sensitivity is in line with
different other recent studies such as glia cell development in
CNS and growth cone development in PNS (Foehring et al., 2012;
Wuestefeld et al., 2012).
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FIGURE 7 | Morphometric analysis of VEGF effects on mature PC dendrites and cell somata. Analysis of the total dendritic length (one dendrite is
exemplarily labeled in red), circumference of the dendritic arbor and cell soma area (blue encircled) of pEYFP-actin microinjected PCs after a 48 h incubation time.
(A) Untreated PC (p9 + 21 div) and the same PC after VEGF administration for 48 h (B). (C) Changes of morphometric parameters for controls and treated cells are
given in percent; data are provided as means ± SEM. Untreated neurons were defined as control and treated cells were normalized to this control. Data compared to
control were tested for significance using Student’s t-test. n = 20; Scale bars: 50 µm.
Axitinb is a potent and selective inhibitor of VEGF receptor
tyrosine kinases 1–3 (Hu-Lowe et al., 2008). A current study
could show that axitinib has a high specificity to VEGFR-2
(Giddabasappa et al., 2016). Through immunohistochemistry,
qPCR and in situ hybridization we decisively proved VEGFR-2
expression in PCs. By blocking through axitinib treatment,
it is very likely that VEGFR-2 and its corresponding ligand
VEGF mainly mediate crucial effects in developing PCs.
During this time, the growth of PC dendrites was strongly
reduced under axitinib incubation. The qPCR results show
a clear reduction in VEGFR-2 mRNA, and are in line with
the lack of effects on mature PCs. In the present study,
we observed a significant reduction in dendritic length after
axitinib administration, so endogenous VEGF apparently plays
an important role for proper dendritogenesis in neonatal PCs.
Only slight reductions of dendritogenesis parameters between
control and axitinib treated slice cultures were perceived in
the juvenile stage. Thus, our presented data indicate for the
first time that in this phase of development, endogenous VEGF
probably plays a more subordinate role in the physiological
maturation progress of the dendritic arbor. We cannot exclude
the impact of other members of the VEGF familiy in the
maturation of PCs. Focusing on the most active biological form
of the VEGF family, VEGF-A, the presented results verify the
prominent significance of VEGF/VEGFR-2 interaction during
this process. The data are in accordance with other inhibition
studies, which investigated the impact of VEGF inhibitors on
the survival and dendritic outgrowth of neonatal PCs using
primary cultures of p1 mice cerebella (Cvetanovic et al., 2011).
These experiments point out a significant reduction in the
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longest PC dendrite, so that low levels of VEGF negatively
influenced survival and dendritogenesis in PCs. In summary, our
present study demonstrates that low VEGF levels compromise,
yet additional VEGF accelerates PC dendritogenesis and
somatogenesis.
Therapeutic Impact of VEGF
VEGF and their inhibiting antibodies and drugs already
have a high relevance in clinical practice, as it is used
as a therapeutical drug for tumor treatment (Fernando and
Hurwitz, 2004; Hutson et al., 2013), or in diabetic retinopathy
(Das et al., 2015), age-related macular degeneration (Solomon
et al., 2014) and intracranial injuries (Talwar and Srivastava,
2014). Storkebaum et al. (2005) demonstrated that VEGF
administration improves motor performance and halts motor
neuron degeneration in ALS rats. Besides this, in the case of
Parkinson’s disease, VEGF is applied for its neuroprotective
function (Cui et al., 2011). Altered PC miRNA expression
plays an important role in SCA1 pathogenesis. Because of
an increase in miR-150 levels, the expression of VEGF in
PCs is down regulated, which modulates disease pathogenesis
(Rodriguez-Lebron et al., 2013). SCA1 is primarily characterized
by degeneration of the spinocerebellar tracts and the loss
of cerebellar PCs (Durr, 2010; Seidel et al., 2012). One
recent study analyzed SCA1 and demonstrated the supportive
function of VEGF during development (Cvetanovic et al., 2011).
Recently, it was of great interest to discover the VEGF that
acts as a stimulating growth factor in dendritogenesis and
spinogenesis during development, as well as in adulthood.
Profound knowledge of VEGF could allow therapeutic use of
VEGF for a variety of human diseases that affect the neuronal
dendrites such as Down syndrome, Rett syndrome and fragile
X syndrome (Kaufmann and Moser, 2000). In addition, for
patients with focal ischemic infarcts and their resulting neuronal
destruction and degeneration, VEGF could be a promising
agent. Our data strongly indicate that VEGF administration is
able to promote dendrite maturation during development, but
unfortunately, there is a loss of VEGF susceptibility on matured
neurons.
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